Upgrade to SI Premium - Free Trial

Bausch + Lomb Corporation (BLCO)

15.46 +0.11 (0.72%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/5/26)

Latest Headlines

RBC Capital: 'Miebo remains the second-largest Rx DED drug in the US with 22.8% market share' June 5, 2026 8:49 AM - StreetInsider Bausch + Lomb launches preservative-free dry eye drops in US June 1, 2026 6:59 AM - StreetInsider Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States June 1, 2026 6:59 AM - BizWire Form 4 Bausch & Lomb Corp For: May 26 Filed by: VON ESCHENBACH ANDREW C. May 28, 2026 5:51 PM - SEC Filing Form 4 Bausch & Lomb Corp For: May 26 Filed by: Ross Thomas W. Sr. May 28, 2026 5:51 PM - SEC Filing Form 4 Bausch & Lomb Corp For: May 26 Filed by: ROBERTSON RUSSEL C May 28, 2026 5:51 PM - SEC Filing Form 4 Bausch & Lomb Corp For: May 26 Filed by: Paulson John May 28, 2026 5:50 PM - SEC Filing Form 4 Bausch & Lomb Corp For: May 26 Filed by: Ling Karen May 28, 2026 5:50 PM - SEC Filing Form 4 Bausch & Lomb Corp For: May 26 Filed by: KAVANAGH SARAH B May 28, 2026 5:50 PM - SEC Filing Form 4 Bausch & Lomb Corp For: May 26 Filed by: COLLIS STEVEN H May 28, 2026 5:50 PM - SEC Filing Form 4 Bausch & Lomb Corp For: May 26 Filed by: Bernier Nathalie D. May 28, 2026 5:50 PM - SEC Filing Form 4 Bausch & Lomb Corp For: May 26 Filed by: Alfonso Eduardo May 28, 2026 5:37 PM - SEC Filing Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China May 28, 2026 4:15 PM - PR NewsWire Form 4 Bausch & Lomb Corp For: May 22 Filed by: SAUNDERS BRENT L May 26, 2026 4:56 PM - SEC Filing Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference May 21, 2026 7:15 AM - BizWire Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results May 20, 2026 4:49 PM - BizWire Bausch Health Announces 2026 Annual Meeting of Shareholder Results May 19, 2026 4:15 PM - PR NewsWire Bausch + Lomb launches PreserVision AREDS3 eye vitamins in US May 19, 2026 7:01 AM - StreetInsider Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States May 19, 2026 7:00 AM - BizWire Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference May 13, 2026 7:00 AM - PR NewsWire Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference May 12, 2026 4:15 PM - PR NewsWire Needham tracks April prescription trends for Alcon and Bausch + Lomb eye drugs May 8, 2026 9:55 AM - StreetInsider Form 4 Bausch & Lomb Corp For: May 05 Filed by: Eldessouky Sam May 7, 2026 4:44 PM - SEC Filing Form 4 Bausch & Lomb Corp For: May 05 Filed by: Hashad Yehia May 7, 2026 4:43 PM - SEC Filing Form 4 Bausch & Lomb Corp For: May 05 Filed by: Munsch Frederick May 7, 2026 4:37 PM - SEC Filing Form 4 Bausch & Lomb Corp For: May 05 Filed by: Bonnefoy Luc May 7, 2026 4:37 PM - SEC Filing Bausch + Lomb launches advanced vitrectomy cutter in Europe May 7, 2026 7:01 AM - StreetInsider Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe May 7, 2026 7:00 AM - BizWire Bausch + Lomb Announces Second R&D “Teach-in” Webinar May 6, 2026 7:15 AM - BizWire Form 4 Bausch & Lomb Corp For: Apr 30 Filed by: ROBERTSON RUSSEL C May 1, 2026 4:17 PM - SEC Filing Form 4 Bausch & Lomb Corp For: Apr 30 Filed by: Paulson John May 1, 2026 4:16 PM - SEC Filing Form 4 Bausch & Lomb Corp For: Apr 30 Filed by: COLLIS STEVEN H May 1, 2026 4:14 PM - SEC Filing Form 4 Bausch & Lomb Corp For: Apr 30 Filed by: Alfonso Eduardo May 1, 2026 4:13 PM - SEC Filing Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting April 30, 2026 7:00 AM - BizWire Bausch & Lomb Corp. (BLCO) PT Raised to $16 at BofA Securities April 30, 2026 4:35 AM - StreetInsider Bausch & Lomb Corp. (BLCO) PT Lowered to $16 at Evercore ISI April 29, 2026 5:15 PM - StreetInsider BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS April 29, 2026 4:05 PM - PR NewsWire Bausch + Lomb Corporation (BLCO) Tops Q1 EPS by 3c, provides guidance April 29, 2026 7:02 AM - StreetInsider Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook April 29, 2026 6:58 AM - BizWire Form 4 Bausch & Lomb Corp For: Apr 24 Filed by: Stewart Andrew J. April 27, 2026 4:44 PM - SEC Filing Form 4 Bausch & Lomb Corp For: Apr 24 Filed by: Bailey A Robert D April 27, 2026 4:42 PM - SEC Filing Bausch + Lomb launches PreserVision AREDS3 vitamins with B complex April 23, 2026 7:08 AM - StreetInsider Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration April 23, 2026 7:00 AM - BizWire Bausch + Lomb Releases 2025 Sustainability Impact Report April 22, 2026 7:15 AM - BizWire Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program April 16, 2026 7:00 AM - BizWire Bausch Health launches Biafine skincare product online in US April 14, 2026 8:02 AM - StreetInsider Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering April 14, 2026 8:01 AM - PR NewsWire BAUSCH + LOMB receives FDA clearance for vitrectomy cutter April 8, 2026 7:00 AM - StreetInsider Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update April 8, 2026 7:00 AM - BizWire Bausch + Lomb launches enVista Envy intraocular lenses in Europe April 7, 2026 7:26 AM - StreetInsider Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe April 7, 2026 7:24 AM - BizWire Bausch & Lomb Corp. (BLCO) PT Lowered to $17 at Evercore ISI April 6, 2026 8:16 AM - StreetInsider Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting April 6, 2026 7:00 AM - BizWire Bausch Health to Announce First Quarter 2026 Results on April 29, 2026 March 31, 2026 7:00 AM - PR NewsWire Bausch + Lomb Will Release First-Quarter 2026 Financial Results on April 29 March 30, 2026 7:15 AM - BizWire Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program March 26, 2026 8:00 AM - PR NewsWire Bausch + Lomb reports positive 24-month trial data for glaucoma treatment March 23, 2026 7:01 AM - StreetInsider Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma March 23, 2026 7:00 AM - BizWire RBC Capital on Bausch & Lomb Corp. (BLCO): 'We view the delay in anticipated competition in the US Rx DED market as neutral to slightly positive' March 17, 2026 9:36 AM - StreetInsider Bausch + Lomb Corporation Investigated by the Portnoy Law Firm March 13, 2026 9:00 AM - Globe NewsWire Form 4 Bausch & Lomb Corp For: Mar 06 Filed by: Bailey A Robert D March 10, 2026 5:24 PM - SEC Filing Form 4 Bausch & Lomb Corp For: Mar 06 Filed by: Eldessouky Sam March 10, 2026 4:34 PM - SEC Filing Form 4 Bausch & Lomb Corp For: Mar 06 Filed by: SAUNDERS BRENT L March 10, 2026 4:32 PM - SEC Filing Bausch + Lomb Launches R&D “Teach-in” Webinar Series March 9, 2026 7:15 AM - BizWire Full Article List